Literature for peptidase C78.002: UfSP2 peptidase

(Topics flags: S Structure, M Mutation, K Knockout. To select only the references relevant to a single topic, click the link above. See explanation.)

2025
1. Zhao,S., Zhang,Y., Li,C., Zheng,Z. and Ma,M.
   Succinate-mediated Ufsp2 transcription promotes high glucose-stimulated pyroptosis in rat retinal Muller cells by activating NLRP3 inflammasome
   Biochem Biophys Res Commun (2025) 783, 152614-152614. PubMed  Europe PubMed DOI  K
2023
2. Mattern,L., Begemann,M., Delbruck,H., Holschbach,P., Schroder,S., Schacht,S.M., Kurth,I. and Elbracht,M.
   Variant of the catalytic cysteine of UFSP2 leads to spondyloepimetaphyseal dysplasia type Di Rocco
   Bone Rep (2023) 18, 101683-101683. PubMed  Europe PubMed DOI  PMC  EPMC
2020
3. Zhang,G., Tang,S., Wang,H., Pan,H., Zhang,W., Huang,Y., Kong,J., Wang,Y., Gu,J. and Wang,Y.
   UFSP2-related spondyloepimetaphyseal dysplasia: A confirmatory report
   Eur J Med Genet (2020) 63, 104021-104021. PubMed  Europe PubMed DOI
2018
4. Di Rocco,M., Rusmini,M., Caroli,F., Madeo,A., Bertamino,M., Marre-Brunenghi,G. and Ceccherini,I.
   Novel spondyloepimetaphyseal dysplasia due to UFSP2 gene mutation
   Clin Genet (2018) 93, 671-674. PubMed  Europe PubMed DOI  M
2015
5. Watson,C.M., Crinnion,L.A., Gleghorn,L., Newman,W.G., Ramesar,R., Beighton,P. and Wallis,G.A.
   Identification of a mutation in the ubiquitin-fold modifier 1-specific peptidase 2 gene, UFSP2, in an extended South African family with Beukes hip dysplasia
   S Afr Med J (2015) 105, 558-563. PubMed  Europe PubMed DOI  M
2014
6. Chen,C., Itakura,E., Weber,K.P., Hegde,R.S. and de Bono,M.
   An ER complex of ODR-4 and ODR-8/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanism
   PLoS Genet (2014) 10, e1004082-e1004082. PubMed  Europe PubMed DOI  PMC  EPMC
7. Yoo,H.M., Kang,S.H., Kim,J.Y., Lee,J.E., Seong,M.W., Lee,S.W., Ka,S.H., Sou,Y.S., Komatsu,M., Tanaka,K., Lee,S.T., Noh,D.Y., Baek,S.H., Jeon,Y.J. and Chung,C.H.
   Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and breast cancer development
   Mol Cell (2014) 56, 261-274. PubMed  Europe PubMed DOI
2011
8. Ha,B.H., Jeon,Y.J., Shin,S.C., Tatsumi,K., Komatsu,M., Tanaka,K., Watson,C.M., Wallis,G., Chung,C.H. and Kim,E.E.
   Structure of ubiquitin-fold modifier 1-specific protease UfSP2
   J Biol Chem (2011) 286, 10248-10257. PubMed  Europe PubMed DOI  S
2007
9. Kang,S.H., Kim,G.R., Seong,M., Baek,S.H., Seol,J.H., Bang,O.S., Ovaa,H., Tatsumi,K., Komatsu,M., Tanaka,K. and Chung,C.H.
   Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2
   J Biol Chem (2007) 282, 5256-5262. PubMed  Europe PubMed DOI
2004
10. [YEAR:5-5-2004]Komatsu,M., Chiba,T., Tatsumi,K., Iemura,S., Tanida,I., Okazaki,N., Ueno,T., Kominami,E., Natsume,T. and Tanaka,K.
    A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier
    EMBO J (5-5-2004) 23, 1977-1986. PubMed  Europe PubMed DOI  PMC  EPMC